Company Search:
Advanced Search
Sponsored Links
China National Medicines Corp., Ltd. Company Snapshot
China National Medicines Corp., Ltd. operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares China National Medicines Corp., Ltd. with three other drug stores in Asia: Pharmaniaga Berhad of Malaysia (2016 sales of 2.19 billion Malaysian Ringgits [US$494.59 million] of which 98% was Logistics and Distribution), Hokuyaku Takeyama Holdings, Inc of Japan (225.15 billion Japanese Yen [US$2.02 billion] of which 72% was Pharmaceutical Business), and Jiangsu Nhwa Pharmaceutical Company Limited (3.02 billion Chinese Renmimbi [US$438.29 million] of which 55% was Medical Industrial Manufacturing).

Sales Analysis. During the year ended December of 2016, sales at China National Medicines Corp., Ltd. were 13.39 billion Chinese Renmimbi (US$1.94 billion). This is an increase of 10.8% versus 2015, when the company's sales were 12.08 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at China National Medicines Corp., Ltd. (and since 2011, sales have increased a total of 90%). Sales of Business Department saw an increase of 11.3% in 2016, from 11.67 billion Chinese Renmimbi to 12.99 billion Chinese Renmimbi. Not all segments of China National Medicines Corp., Ltd. experienced an increase in sales in 2016: sales of Other fell 3.7% to 395.80 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
China National Medicines Corp., Ltd.
  Stock Performance Chart for China National Medicines Corp., Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 33.80
(Figures in Chinese Renmimbi)
1 Week 5.5%   13 Weeks 0.1%  
4 Weeks 10.9%   52 Weeks n/a  
China National Medicines Corp., Ltd. Key Data:
  Ticker: 600511 Country: China
  Exchanges: SHG Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 13,385,930,639
(Year Ending Jan 2017).
Employees: 1,790
  Currency: Chinese Renmimbi Market Cap: 16,183,440,000
  Fiscal Yr Ends: December Shares Outstanding: 478,800,000
  Share Type: A Gu Closely Held Shares: 239,661,642
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.